X-twitter Facebook-square Linkedin-in Youtube-square Ti-instagram

acute coronary syndrome

Chest Pain Controversies: Coronary CTA Use (Part 2)

1 Comment / practice updates /

Coronary CTA has risen to the forefront of chest pain evaluation, providing an anatomical evaluation of coronary artery vasculature. When negative, it improves negative predictive value of ACS. Additionally, CCTA allows for a better means to diagnose CAD when compared to history, physical exam, ECG, and biomarkers. But, is CCTA useful to further risk stratify low-risk patients? Who might benefit from CCTA and what are the risks?

Chest Pain Controversies: Coronary CTA Use (Part 2) Read More »

Chest Pain Controversies: Risk Stratification and Stress Test Utility (Part 1)

2 Comments / practice updates /

Chest pain accounts for approximately 8-10 million healthcare visits in the U.S. per year and can be associated with a variety of benign to life-threatening diseases. Acute coronary syndrome is one of the major considerations in the ED. Approximately 20% of lawsuits are due to misdiagnosis and mismanagement of ACS and a large percentage of patients are admitted due to this risk. However, few admitted patients go on to be diagnosed with ACS. Although commonly used to help risk stratify patients in the ED, there is no evidence that stress testing decreases risk of future cardiac events. This post will examine chest pain risk stratification in the ED and the utility of stress testing.

Chest Pain Controversies: Risk Stratification and Stress Test Utility (Part 1) Read More »

Subscribe
Subscribe
A 64 year old male presents to the ed with shortness of breath and abdominal pain. Magnetic resonance imaging in primary progressive multiple sclerosis patients : review. About sexual generics.